top of page
Search

Qaelon and RevMedica

Updated: May 5

ree

At Qaelon Medical, our mission has always been clear—to eliminate the devastating impact of surgical leaks through real-time detection and actionable insights. Today, we’re taking a big step forward by partnering with RevMedica, Inc. - an innovator in precision surgical stapling, to push the boundaries of surgical intelligence and improve clinical outcomes.By using Qaelon Medical’s real-time leak detection technology with RevMedica’s advanced stapling solutions, we are enhancing surgical precision—providing surgeons with actionable data to optimize staple line performance, accelerate innovation, and improve patient outcomes in real time. This is more than a partnership—it’s a major step toward changing surgery with intelligent, data-powered decision-making. We are honored to be working with RevMedica, Inc. and can’t wait to see the impact this will have on patients worldwide. 



 
 
 

Recent Posts

See All
Bringing Qaelon’s voice to LSI Europe 2025

CEO, Liam J. Burns, will speak at LSI Europe 2025 in London on the panel: “Pre-clinical Perspectives: Navigating the Investor and Regulatory Landscape Before First in Human.”

 
 
 

Comments


Note: Qaelon Medical products are currently under development, have not been cleared by the FDA, and are not yet available for commercial sale in the United States or Europe.

Qaelon Medical, IHU, 1 Place de l’Hôpital

67091 Strasbourg, France

Email: yee-ying.douchamps@qaelonmedical.com

  • LinkedIn

© 2025 Qaelon Medical

bottom of page